OTC · Biotechnology

Evelo Biosciences, Inc. (EVLO) Stock

$0.00 OTC: EVLO Healthcare

Evelo Biosciences, Inc. is a biotechnology firm dedicated to identifying and advancing oral biologic therapies for various inflammatory conditions and oncological diseases.

Valuation

MetricValue
Price$0.00
Market Cap$1898
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-26.28
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE2300.00%
ROA-179.69%
ROCE-208.40%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-10.20
Current Ratio4.33

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$-58.0M$-86.0M$-92.0M$-115.0M$-108.0M
Net Profit$-54.0M$-86.0M$-94.0M$-122.0M$-115.0M
EPS$-49.25$-53.49$-47.45$-46.18$-26.28
Op Margin—————

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$160.0M$91.0M$91.0M$88.0M$64.0M
Total Liabilities$23.0M$31.0M$60.0M$79.0M$69.0M
Cash$148.0M$78.0M$69.0M$68.0M$48.0M
Borrowings$12.0M$20.0M$40.0M$56.0M$51.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-47.0M$-72.0M$-73.0M$-97.0M$-101.0M
Investing Cash Flow$-66.0M$49.0M$-3.0M$-3.0M$-1.0M
Financing Cash Flow$0$1.0M$0$1.0M$0
Net Cash Flow$55.0M$-15.0M$-9.0M$-1.0M$-21.0M
Free Cash Flow$-53.0M$-75.0M$-74.0M$-98.0M$-102.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.03
FCF Yield-5366543.73%
Quick Ratio4.16
Interest Coverage-23.22
Return 1Y-80.00%
Return 3Y-100.00%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARDSAridis Pharmaceuticals, Inc. $0.00 — 0.00 $4457 0.00%
BTAXBiostax Corp. $0.00 — 0.00 $7871 0.00%
HSTCHST Global, Inc. $0.70 +0.00% -250.00 $29.94M 0.00%
ICCTiCoreConnect Inc. $0.00 — 0.00 $5365 0.00%
INFIQInfinity Pharmaceuticals, Inc. $0.00 — 0.00 $9076 0.00%

About Evelo Biosciences, Inc.

Evelo Biosciences, Inc. is a biotechnology firm dedicated to identifying and advancing oral biologic therapies for various inflammatory conditions and oncological diseases. Its pipeline includes EDP1815, a whole-microbe compound designed to address inflammatory ailments, currently undergoing Phase 2 clinical trials for conditions such as psoriasis and atopic dermatitis, and also being evaluated for the hyperinflammatory reaction associated with COVID-19. Additional developments include EDP1867, an inactivated oral biologic in Phase 1b for inflammatory diseases; EDP2939, an investigational oral biologic based on extracellular vesicles targeting inflammatory diseases; and EDP1908, a drug candidate focused on cancer. Established in 2014, Evelo Biosciences, Inc. operates from its headquarters in Cambridge, Massachusetts.

Evelo Biosciences, Inc. (EVLO) stock trades at $0.00 with a market capitalization of $1898. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Evelo Biosciences, Inc. generates a return on equity (ROE) of 2300.00% — well above the market average, a sign of a high-quality business, return on capital employed of -208.40%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.evelobio.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides